Polyomavirus reactivation in pediatric patients with systemic lupus erythematosus

Tohoku Journal of Experimental Medicine

Volumn 228, Issue 3, 2012, Pages 197-204

  Rianthavorn, Pornpimol ^a   Posuwan, Nawarat ^a   Payungporn, Sunchai ^a   Theamboonlers, Apiradee ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Pediatrics; Polyomavirus; Reactivation; Systemic lupus erythematosus; Viruria

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; BK VIRUS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DOSE RESPONSE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JC VIRUS; KI VIRUS; MALE; MERKEL CELL POLYOMAVIRUS; PAPOVAVIRUS; PEDIATRICS; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRICHODYSPLASIA SPINULOSA VIRUS; VIRUS ISOLATION; VIRUS REACTIVATION; WU VIRUS;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CYCLOPHOSPHAMIDE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; PREVALENCE; RECURRENCE; THAILAND; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84867841970     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.228.197     Document Type: Review

References (33)

1. Abend, J.R. & Imperiale, M.J. (2008) Transforming growth factor-beta-mediated regulation of BK virus gene expression. Virology, 378, 6-12.
2. Becker-Merok, A., Eilertsen, G.O. & Nossent, J.C. (2010) Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease. J. Rheumatol., 37, 2039-2045.
3. Colla, L., Mesiano, P., Morellini, V., Besso, L., Cavallo, R., Bergallo, M., Costa, C., Merlino, C., Marcuccio, C., Fop, F., Lanfranco, G., Segoloni, G.P., Canavese, C. & Stratta, P. (2007) Human polyomavirus BK in patients with lupus nephritis: clinical and histological correlations. Lupus, 16, 881-886.
4. Csoma, E., Meszaros, B., Asztalos, L., Konya, J. & Gergely, L. (2011) Prevalence of WU and KI polyomaviruses in plasma, urine, and respiratory samples from renal transplant patients. J. Med. Virol., 83, 1275-1278.
5. Dadhania, D., Snopkowski, C., Ding, R., Muthukumar, T., Chang, C., Aull, M., Lee, J., Sharma, V.K., Kapur, S. & Suthanthiran, M. (2008) Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation, 86, 521-528.
6. Fenton, K.A., Mjelle, J.E., Jakobsen, S., Olsen, R. & Rekvig, O.P. (2008) Renal expression of polyomavirus large T antigen is associated with nephritis in human systemic lupus erythematosus. Mol. Immunol., 45, 3117-3124.
7. Flaegstad, T., Fredriksen, K., Dahl, B., Traavik, T. & Rekvig, O.P. (1988) Inoculation with BK virus may break immunological tolerance to histone and DNA antigens. Proc. Natl. Acad. Sci. USA, 85, 8171-8175.
8. Fredriksen, K., Osei, A., Sundsfjord, A., Traavik, T. & Rekvig, O.P. (1994) On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related antidsDNA antibodies are induced by polyomavirus BK in lupusprone (NZB × NZW) F1 hybrids, but not in normal mice. Eur. J. Immunol., 24, 66-70.
9. Fredriksen, K., Skogsholm, A., Flaegstad, T., Traavik, T. & Rekvig, O.P. (1993) Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related to virus replication in vivo. Scand. J. Immunol., 38, 401-406.
10. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
11. Hoffman, I.E., Lauwerys, B.R., De Keyser, F., Huizinga, T.W., Isenberg, D., Cebecauer, L., Dehoorne, J., Joos, R., Hendrickx, G., Houssiau, F. & Elewaut, D. (2009) Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann. Rheum. Dis., 68, 412-415.
12. Kakeji, Y., Maehara, Y., Ikebe, M. & Teicher, B.A. (1997) Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 37, 1115-1123.
13. Khanna, A., Cairns, V. & Hosenpud, J.D. (1999) Tacrolimus induces increased expression of transforming growth factorbeta1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation, 67, 614-619.
14. Lu, M.C., Yu, C.L., Yin, W.Y., Tung, C.H., Huang, K.Y., Liu, S.Q. & Lai, N.S. (2009) Increased prevalence of polyomavirus BK viruria that correlates with thrombocytopenia in patients with systemic lupus erythematosus on intensive immunosuppressive therapy. Autoimmunity, 42, 216-223.
15. Matsumoto, K. & Hatano, M. (1984) Defective cellular immune responses in lupus nephritis. J. Clin. Lab. Immunol., 14, 161-163.
16. Mo, H.Y., Wang, L.F., Xu, J., Shi, Y.H., Yang, M. & Zhou, R.H. (2011) The effect of cyclophosphamide on cytokines in patients with primary Sjogren's syndrome-associated interstitial lung disease. Zhonghua Jie He He Hu Xi Za Zhi, 34, 495-499.
17. Murakami, K., Takemura, T., Hino, S. & Yoshioka, K. (1997) Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr. Nephrol., 11, 334-336.
18. Nali, L.H., Centrone Cde, C., Urbano, P.R., Penalva-de-Oliveira, A.C., Vidal, J.E., Miranda, E.P., Pannuti, C.S. & Fink, M.C. (2012) High prevalence of the simultaneous excretion of polyomaviruses JC and BK in the urine of HIV-infected patients without neurological symptoms in Sao Paulo, Brazil. Rev. I. Med. Trop., 54, 201-205.
19. Nowak, M., Wyczalkowska-Tomasik, A., Wlodarczyk, Z. & Paczek, L. (2012) The role of the kidney in the systemic elimination of interleukin 6, platelet-derived growth factor and transforming growth factor beta. Cytokine, 59, 258-263.
20. Palazzo, E. & Yahia, S.A. (2012) Progressive multifocal leukoencephalopathy in autoimmune diseases. Joint Bone Spine, 79, 351-355.
21. Randhawa, P. & Brennan, D.C. (2006) BK virus infection in transplant recipients: an overview and update. Am. J. Transplant., 6, 2000-2005.
22. Ravichandran, V., Jensen, P.N. & Major, E.O. (2007) MEK1/2 inhibitors block basal and transforming growth factor 1beta1-stimulated JC virus multiplication. J. Virol., 81, 6412-6418.
23. Rekvig, O.P., Moens, U., Sundsfjord, A., Bredholt, G., Osei, A., Haaheim, H., Traavik, T., Arnesen, E. & Haga, H.J. (1997) Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J. Clin. Invest., 99, 2045-2054.
24. Saito, H., Sakai, H., Fujihara, K. & Itoyama, Y. (1998) Progressive multifocal leukoencephalopathy in a patient with acquired immunodeficiency syndrome (AIDS) manifesting Gerstmann's syndrome. Tohoku J. Exp. Med., 186, 169-179.
25. Shihab, F.S., Andoh, T.F., Tanner, A.M., Noble, N.A., Border, W.A., Franceschini, N. & Bennett, W.M. (1996) Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int., 49, 1141-1151.
26. Stettner, M.R., Nance, J.A., Wright, C.A., Kinoshita, Y., Kim, W.K., Morgello, S., Rappaport, J., Khalili, K., Gordon, J. & Johnson, E.M. (2009) SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. J. Gen. Virol., 90, 2005-2014.
27. Stolt, A., Sasnauskas, K., Koskela, P., Lehtinen, M. & Dillner, J. (2003) Seroepidemiology of the human polyomaviruses. J. Gen. Virol., 84, 1499-1504.
28. Sundsfjord, A., Osei, A., Rosenqvist, H., Van Ghelue, M., Silsand, Y., Haga, H.J., Rekvig, O.P. & Moens, U. (1999) BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J. Infect. Dis., 180, 1-9.
29. Taguchi, F., Hara, K. & Nagaki, D. (1978) BK papovavirus in urine of a patient with systemic lupus erythematosus. Acta Virol., 22, 513.
30. Tyagi, P., Tyagi, V., Yoshimura, N., Witteemer, E., Barclay, D., Loughran, P.A., Zamora, R. & Vodovotz, Y. (2009) Genderbased reciprocal expression of transforming growth factorbeta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis. J. Inflamm. (Lond), 6, 23.
31. Wang, M., Tsai, R.T., Ou, W.C., Lin, C.K., Tsay, G.J., Chang, H. & Chang, D. (2000) Treatment with cytotoxic immunosuppression agents increases urinary excretion of JCV in patients with autoimmune disease. J. Med. Virol., 62, 505-510.
32. Weening, J.J., D'Agati, V.D., Schwartz, M.M., Seshan, S.V., Alpers, C.E., Appel, G.B., Balow, J.E., Bruijn, J.A., Cook, T., Ferrario, F., Fogo, A.B., Ginzler, E.M., Hebert, L., Hill, G., Hill, P., Jennette, J.C., Kong, N.C., Lesavre, P., Lockshin, M., Looi, L.M., Makino, H., Moura, L.A. & Nagata, M. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol., 15, 241-250.
33. Zhong, S., Zheng, H.Y., Suzuki, M., Chen, Q., Ikegaya, H., Aoki, N., Usuku, S., Kobayashi, N., Nukuzuma, S., Yasuda, Y., Kuniyoshi, N., Yogo, Y. & Kitamura, T.(2007) Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J. Clin. Microbiol., 45, 193-198.